Severe influenza among children and young adults with neurologic and neurodevelopmental conditions - Ohio, 2011

Morbidity and Mortality Weekly Report

Volumn 60, Issue 51-52, 2012, Pages 1729-1733

  Diorio, Mary ^a   de Fijter, Sietske ^a   Schwartz, Mindy ^a   Page, Shannon L ^a   Jhung, Michael A ^b   Finelli, Lyn ^b   Peacock, Georgina ^c   Yeung, Lorraine F ^c   Honein, Margaret A ^c   Moore, Cynthia A ^c   Azofeifa, Alejandro ^d   Rodgers, Loren ^d   Graitcer, Samuel E ^d  

^a OHIO DEPARTMENT OF HEALTH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHILD; DELAYED DIAGNOSIS; DEVELOPMENTAL DISORDER; EPIDEMIC; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INTERPERSONAL COMMUNICATION; MALE; PRESCHOOL CHILD; RESIDENTIAL HOME; UNITED STATES;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNICATION; DELAYED DIAGNOSIS; DEVELOPMENTAL DISABILITIES; DISEASE OUTBREAKS; FATAL OUTCOME; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; OHIO; RESIDENTIAL FACILITIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84855669381     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cox CM, Blanton L, Dhara R, et al. 2009 pandemic influenza A (H1N1) deaths among children-United States 2009-2010. Clinical Infec Dis 2011;52(Suppl 1):S69-74.
2. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005;294:2188-94.
3. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005;353:2559-67.
4. CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60(No. RR-1).
5. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32.
6. Herrera GA, Iwane MK, Cortese M, et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 2007;25:154-60.
7. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011;29:9159-70.
8. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003;37:1094-101.
9. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:93-7.
10. CDC. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60(No. RR-2).